|
YWHAE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.2759999999945E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08379999996799E-06 |
| Normal-vs-Stage2 |
2.260200E-01 |
| Normal-vs-Stage3 |
2.170400E-01 |
| Normal-vs-Stage4 |
6.888600E-01 |
| Stage1-vs-Stage2 |
2.021800E-01 |
| Stage1-vs-Stage3 |
1.751570E-01 |
| Stage1-vs-Stage4 |
1.864220E-01 |
| Stage2-vs-Stage3 |
9.579600E-01 |
| Stage2-vs-Stage4 |
7.149800E-01 |
| Stage3-vs-Stage4 |
7.092600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61470000004105E-06 |
| Normal-vs-AfricanAmerican |
1.882640E-03 |
| Normal-vs-Asian |
6.244000E-01 |
| Caucasian-vs-AfricanAmerican |
4.981000E-01 |
| Caucasian-vs-Asian |
4.899800E-01 |
| AfricanAmerican-vs-Asian |
5.549200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67506999999567E-05 |
| Normal-vs-Female |
6.783000E-04 |
| Male-vs-Female |
5.414800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.522790E-01 |
| Normal-vs-Extreme_Weight |
7.380200E-04 |
| Normal-vs-Obese |
2.232700E-04 |
| Normal-vs-Extreme_Obese |
1.887750E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.587400E-01 |
| Normal_Weight-vs-Obese |
3.004800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.540400E-01 |
| Extreme_Weight-vs-Obese |
8.542600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.786400E-01 |
| Obese-vs-Extreme_Obese |
8.948200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.861870E-02 |
| Normal-vs-Age(41-60Yrs) |
5.35930000045148E-07 |
| Normal-vs-Age(61-80Yrs) |
6.433800E-04 |
| Normal-vs-Age(81-100Yrs) |
4.114000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.750000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.541200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.034400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.083700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.502500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.327800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.55204795868758E-12 |
| Normal-VS-Type2 PRCC |
6.426800E-01 |
| Normal-VS-KIRP CIMP |
2.790000E-01 |
| Normal-VS-Unclassified PRCC |
4.711800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.08200001683423E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.846250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.043800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.855980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.964400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.578600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.377600E-01 |
| Normal-vs-N1 |
1.860400E-02 |
| Normal-vs-N2 |
3.224400E-01 |
| N0-vs-N1 |
1.989760E-01 |
| N0-vs-N2 |
1.336190E-01 |
| N1-vs-N2 |
2.578200E-02 |
|
|
